Hospital devices Medical devices

The medical devices information portal connecting healthcare professionals to global vendors

Surgical/ OR

Bifurcated drug-eluting stent

Bifurcated drug-eluting stent. Eighteen to twenty percent of percutaneous coronary interventions involve a bifurcation stenosis. Of those, restenosis occurs in 20-25% of bifurcations treated with drug-eluting stents (DES). In September 2007 the next-generation Stentys bifurcated stent was successfully implanted into a 56-year-old male patient at the Helios Klinikum in Siegburg, Germany. This first-in-man medical milestone took routine interventional time to complete; the patient was released from the ICU within hours of the implantation and was discharged from the hospital shortly after the procedure. The innovation of the bifurcated stent is that the stent opening for the side branch can be created anywhere in the stent after it is implanted in the vessel. In short, the procedure's success is independent from accurate positioning. The procedure is performed in three simple steps, and the system's self-expanding property allows the in situ modelling of the stent to fit the patient's unique arterial anatomy.

Bifurcated drug-eluting stent

Stentys SAS

Show me the supplier details
Supplier details
Download above product as PDF file
Download above as PDF

Contact form

Get in touch directly with the above supplier

Pre-fill this form automatically in My IHE

Last name:*
Job title:*
Postal code:*
Email (confirm):*
Your email address will not be communicated to any third party other than the above supplier for the purpose of fulfilling this enquiry. For more information: IHE's privacy policy
  Send product data
Send price data
Send dealer data
  I would like to receive IHE's electronic publications

IHE :: Your advertise here !